NCT01063478 Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC Status TERMINATED Phase PHASE1
NCT01061788 A Trial of AMG 479, Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer - QUILT-3.007 Status COMPLETED Phase PHASE1
NCT01061177 Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome & /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase Status COMPLETED Phase PHASE4
NCT01060865 Evaluation of Aliskiren Efficacy by Different Methods of Blood Pressure Measurements Status TERMINATED Phase PHASE4
NCT01059318 A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis Status COMPLETED Phase PHASE2
NCT01058434 Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation Status COMPLETED Phase PHASE2
NCT01056822 Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza Study. Status COMPLETED Phase PHASE4
NCT01056601 Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy Status TERMINATED Phase PHASE2
NCT01055483 A Phase Ib, Open-label, Multi-center Dose-finding Study of Oral Panobinostat (LBH589) in Combination With Ara-C and Mitoxantrone as Salvage Therapy for Refractory or Relapsed Acute Myeloid Leukemia Status COMPLETED Phase PHASE1
NCT01051817 POC-MD MRI-based Trial in Relapsing-remitting Multiple Scler Status COMPLETED Phase PHASE2
NCT01047579 A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease Status COMPLETED Phase PHASE4
NCT01044667 A Gastrointestinal Quality of Life Study in Lung Transplant Recipients Converted From Mycophenolate Mofetil to Myfortic Status TERMINATED Phase NA
NCT01044303 Reducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study) Status COMPLETED Phase PHASE4
NCT01044186 A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity Status COMPLETED Phase PHASE2
NCT01043874 Study to Evaluate Nilotinib in Chronic Myelogenous Leukemia (CML) Patients With SubOptimal Response Status COMPLETED Phase PHASE4
NCT01039376 Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy Status TERMINATED Phase PHASE3
NCT01035255 This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure Status TERMINATED Phase PHASE3
NCT01035229 Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma. Status COMPLETED Phase PHASE3